共 50 条
Do we still need chemotherapy for AIDS-associated Kaposi's sarcoma?
被引:1
作者:
Dalla Pria, Alessia
[1
]
Hayward, Katy
[1
]
Bower, Mark
[1
]
机构:
[1] Chelsea & Westminster Hosp, Natl Ctr HIV Malignancy, London SW10 9NH, England
关键词:
AIDS;
antiretrovirals;
chemotherapy;
HIV;
Kaposi sarcoma;
ACTIVE ANTIRETROVIRAL THERAPY;
RECONSTITUTION INFLAMMATORY SYNDROME;
PEGYLATED-LIPOSOMAL DOXORUBICIN;
VASCULAR-PERMEABILITY FACTOR;
PHASE-III TRIAL;
IMMUNE RECONSTITUTION;
DNA-SEQUENCES;
MALIGNANCY CONSORTIUM;
INFECTED INDIVIDUALS;
PROTEASE INHIBITORS;
D O I:
10.1586/ERA.12.179
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
The widespread introduction of effective combination antiretroviral therapy (cART) has had a major influence on the epidemiology and natural history of AIDS-associated Kaposi's sarcoma (AIDS-KS). cART has reduced the incidence of AIDS-KS, and it has been shown to be an effective treatment for early-stage KS. So with the widespread availability of cART, is systemic chemotherapy still required for AIDS-KS? Two indications appear to remain: advanced-stage AIDS-KS and patients who have progressive KS despite effective cART including immune reconstitution inflammatory syndrome KS.
引用
收藏
页码:203 / 209
页数:7
相关论文